Report Overview
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.
The global Neuroblastoma Treatment market size was estimated at USD 444 million in 2023 and is projected to reach USD 605.13 million by 2032, exhibiting a CAGR of 3.50% during the forecast period.
North America Neuroblastoma Treatment market size was estimated at USD 122.74 million in 2023, at a CAGR of 3.00% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Neuroblastoma Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neuroblastoma Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neuroblastoma Treatment market in any manner.
Global Neuroblastoma Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Seattle Children
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neuroblastoma Treatment
1.2 Key Market Segments
1.2.1 Neuroblastoma Treatment Segment by Type
1.2.2 Neuroblastoma Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neuroblastoma Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Neuroblastoma Treatment Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Neuroblastoma Treatment Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neuroblastoma Treatment Market Competitive Landscape
3.1 Global Neuroblastoma Treatment Sales by Manufacturers (2019-2025)
3.2 Global Neuroblastoma Treatment Revenue Market Share by Manufacturers (2019-2025)
3.3 Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neuroblastoma Treatment Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Neuroblastoma Treatment Sales Sites, Area Served, Product Type
3.6 Neuroblastoma Treatment Market Competitive Situation and Trends
3.6.1 Neuroblastoma Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neuroblastoma Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neuroblastoma Treatment Industry Chain Analysis
4.1 Neuroblastoma Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neuroblastoma Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neuroblastoma Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neuroblastoma Treatment Sales Market Share by Type (2019-2025)
6.3 Global Neuroblastoma Treatment Market Size Market Share by Type (2019-2025)
6.4 Global Neuroblastoma Treatment Price by Type (2019-2025)
7 Neuroblastoma Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neuroblastoma Treatment Market Sales by Application (2019-2025)
7.3 Global Neuroblastoma Treatment Market Size (M USD) by Application (2019-2025)
7.4 Global Neuroblastoma Treatment Sales Growth Rate by Application (2019-2025)
8 Neuroblastoma Treatment Market Consumption by Region
8.1 Global Neuroblastoma Treatment Sales by Region
8.1.1 Global Neuroblastoma Treatment Sales by Region
8.1.2 Global Neuroblastoma Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Neuroblastoma Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neuroblastoma Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neuroblastoma Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neuroblastoma Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neuroblastoma Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Neuroblastoma Treatment Market Production by Region
9.1 Global Production of Neuroblastoma Treatment by Region (2019-2025)
9.2 Global Neuroblastoma Treatment Revenue Market Share by Region (2019-2025)
9.3 Global Neuroblastoma Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Neuroblastoma Treatment Production
9.4.1 North America Neuroblastoma Treatment Production Growth Rate (2019-2025)
9.4.2 North America Neuroblastoma Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Neuroblastoma Treatment Production
9.5.1 Europe Neuroblastoma Treatment Production Growth Rate (2019-2025)
9.5.2 Europe Neuroblastoma Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Neuroblastoma Treatment Production (2019-2025)
9.6.1 Japan Neuroblastoma Treatment Production Growth Rate (2019-2025)
9.6.2 Japan Neuroblastoma Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Neuroblastoma Treatment Production (2019-2025)
9.7.1 China Neuroblastoma Treatment Production Growth Rate (2019-2025)
9.7.2 China Neuroblastoma Treatment Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Seattle Children
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neuroblastoma Treatment Market Size Comparison by Region (M USD)
Table 5. Global Neuroblastoma Treatment Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Neuroblastoma Treatment Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Neuroblastoma Treatment Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Neuroblastoma Treatment Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2022)
Table 10. Global Market Neuroblastoma Treatment Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Neuroblastoma Treatment Sales Sites and Area Served
Table 12. Manufacturers Neuroblastoma Treatment Product Type
Table 13. Global Neuroblastoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neuroblastoma Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neuroblastoma Treatment Market Challenges
Table 22. Global Neuroblastoma Treatment Sales by Type (K MT)
Table 23. Global Neuroblastoma Treatment Market Size by Type (M USD)
Table 24. Global Neuroblastoma Treatment Sales (K MT) by Type (2019-2025)
Table 25. Global Neuroblastoma Treatment Sales Market Share by Type (2019-2025)
Table 26. Global Neuroblastoma Treatment Market Size (M USD) by Type (2019-2025)
Table 27. Global Neuroblastoma Treatment Market Size Share by Type (2019-2025)
Table 28. Global Neuroblastoma Treatment Price (USD/MT) by Type (2019-2025)
Table 29. Global Neuroblastoma Treatment Sales (K MT) by Application
Table 30. Global Neuroblastoma Treatment Market Size by Application
Table 31. Global Neuroblastoma Treatment Sales by Application (2019-2025) & (K MT)
Table 32. Global Neuroblastoma Treatment Sales Market Share by Application (2019-2025)
Table 33. Global Neuroblastoma Treatment Sales by Application (2019-2025) & (M USD)
Table 34. Global Neuroblastoma Treatment Market Share by Application (2019-2025)
Table 35. Global Neuroblastoma Treatment Sales Growth Rate by Application (2019-2025)
Table 36. Global Neuroblastoma Treatment Sales by Region (2019-2025) & (K MT)
Table 37. Global Neuroblastoma Treatment Sales Market Share by Region (2019-2025)
Table 38. North America Neuroblastoma Treatment Sales by Country (2019-2025) & (K MT)
Table 39. Europe Neuroblastoma Treatment Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Neuroblastoma Treatment Sales by Region (2019-2025) & (K MT)
Table 41. South America Neuroblastoma Treatment Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Neuroblastoma Treatment Sales by Region (2019-2025) & (K MT)
Table 43. Global Neuroblastoma Treatment Production (K MT) by Region (2019-2025)
Table 44. Global Neuroblastoma Treatment Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Neuroblastoma Treatment Revenue Market Share by Region (2019-2025)
Table 46. Global Neuroblastoma Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Neuroblastoma Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Neuroblastoma Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Neuroblastoma Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Neuroblastoma Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Seattle Children?s Neuroblastoma Treatment Basic Information
Table 52. Seattle Children?s Neuroblastoma Treatment Product Overview
Table 53. Seattle Children?s Neuroblastoma Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Seattle Children?s Business Overview
Table 55. Seattle Children?s Neuroblastoma Treatment SWOT Analysis
Table 56. Seattle Children?s Recent Developments
Table 57. CureSearch Neuroblastoma Treatment Basic Information
Table 58. CureSearch Neuroblastoma Treatment Product Overview
Table 59. CureSearch Neuroblastoma Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. CureSearch Business Overview
Table 61. CureSearch Neuroblastoma Treatment SWOT Analysis
Table 62. CureSearch Recent Developments
Table 63. Texas Children?s Neuroblastoma Treatment Basic Information
Table 64. Texas Children?s Neuroblastoma Treatment Product Overview
Table 65. Texas Children?s Neuroblastoma Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Texas Children?s Neuroblastoma Treatment SWOT Analysis
Table 67. Texas Children?s Business Overview
Table 68. Texas Children?s Recent Developments
Table 69. NANT Neuroblastoma Treatment Basic Information
Table 70. NANT Neuroblastoma Treatment Product Overview
Table 71. NANT Neuroblastoma Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. NANT Business Overview
Table 73. NANT Recent Developments
Table 74. Sino Biopharmaceutical Neuroblastoma Treatment Basic Information
Table 75. Sino Biopharmaceutical Neuroblastoma Treatment Product Overview
Table 76. Sino Biopharmaceutical Neuroblastoma Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Sino Biopharmaceutical Business Overview
Table 78. Sino Biopharmaceutical Recent Developments
Table 79. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Basic Information
Table 80. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Overview
Table 81. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 83. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
Table 84. Fosun Pharmaceutical Neuroblastoma Treatment Basic Information
Table 85. Fosun Pharmaceutical Neuroblastoma Treatment Product Overview
Table 86. Fosun Pharmaceutical Neuroblastoma Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Fosun Pharmaceutical Business Overview
Table 88. Fosun Pharmaceutical Recent Developments
Table 89. Novartis Neuroblastoma Treatment Basic Information
Table 90. Novartis Neuroblastoma Treatment Product Overview
Table 91. Novartis Neuroblastoma Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Novartis Business Overview
Table 93. Novartis Recent Developments
Table 94. Juno Therapeutics Neuroblastoma Treatment Basic Information
Table 95. Juno Therapeutics Neuroblastoma Treatment Product Overview
Table 96. Juno Therapeutics Neuroblastoma Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Juno Therapeutics Business Overview
Table 98. Juno Therapeutics Recent Developments
Table 99. Kite Pharma Neuroblastoma Treatment Basic Information
Table 100. Kite Pharma Neuroblastoma Treatment Product Overview
Table 101. Kite Pharma Neuroblastoma Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Kite Pharma Business Overview
Table 103. Kite Pharma Recent Developments
Table 104. Adaptimmune Neuroblastoma Treatment Basic Information
Table 105. Adaptimmune Neuroblastoma Treatment Product Overview
Table 106. Adaptimmune Neuroblastoma Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Adaptimmune Business Overview
Table 108. Adaptimmune Recent Developments
Table 109. Global Neuroblastoma Treatment Sales Forecast by Region (2025-2032) & (K MT)
Table 110. Global Neuroblastoma Treatment Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America Neuroblastoma Treatment Sales Forecast by Country (2025-2032) & (K MT)
Table 112. North America Neuroblastoma Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Neuroblastoma Treatment Sales Forecast by Country (2025-2032) & (K MT)
Table 114. Europe Neuroblastoma Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific Neuroblastoma Treatment Sales Forecast by Region (2025-2032) & (K MT)
Table 116. Asia Pacific Neuroblastoma Treatment Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America Neuroblastoma Treatment Sales Forecast by Country (2025-2032) & (K MT)
Table 118. South America Neuroblastoma Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa Neuroblastoma Treatment Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa Neuroblastoma Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global Neuroblastoma Treatment Sales Forecast by Type (2025-2032) & (K MT)
Table 122. Global Neuroblastoma Treatment Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global Neuroblastoma Treatment Price Forecast by Type (2025-2032) & (USD/MT)
Table 124. Global Neuroblastoma Treatment Sales (K MT) Forecast by Application (2025-2032)
Table 125. Global Neuroblastoma Treatment Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Neuroblastoma Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neuroblastoma Treatment Market Size (M USD), 2019-2032
Figure 5. Global Neuroblastoma Treatment Market Size (M USD) (2019-2032)
Figure 6. Global Neuroblastoma Treatment Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neuroblastoma Treatment Market Size by Country (M USD)
Figure 11. Neuroblastoma Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Neuroblastoma Treatment Revenue Share by Manufacturers in 2023
Figure 13. Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neuroblastoma Treatment Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neuroblastoma Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neuroblastoma Treatment Market Share by Type
Figure 18. Sales Market Share of Neuroblastoma Treatment by Type (2019-2025)
Figure 19. Sales Market Share of Neuroblastoma Treatment by Type in 2023
Figure 20. Market Size Share of Neuroblastoma Treatment by Type (2019-2025)
Figure 21. Market Size Market Share of Neuroblastoma Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neuroblastoma Treatment Market Share by Application
Figure 24. Global Neuroblastoma Treatment Sales Market Share by Application (2019-2025)
Figure 25. Global Neuroblastoma Treatment Sales Market Share by Application in 2023
Figure 26. Global Neuroblastoma Treatment Market Share by Application (2019-2025)
Figure 27. Global Neuroblastoma Treatment Market Share by Application in 2023
Figure 28. Global Neuroblastoma Treatment Sales Growth Rate by Application (2019-2025)
Figure 29. Global Neuroblastoma Treatment Sales Market Share by Region (2019-2025)
Figure 30. North America Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Neuroblastoma Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Neuroblastoma Treatment Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Neuroblastoma Treatment Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Neuroblastoma Treatment Sales Market Share by Country in 2023
Figure 37. Germany Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Neuroblastoma Treatment Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Neuroblastoma Treatment Sales Market Share by Region in 2023
Figure 44. China Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Neuroblastoma Treatment Sales and Growth Rate (K MT)
Figure 50. South America Neuroblastoma Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Neuroblastoma Treatment Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Neuroblastoma Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Neuroblastoma Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Neuroblastoma Treatment Production Market Share by Region (2019-2025)
Figure 62. North America Neuroblastoma Treatment Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Neuroblastoma Treatment Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Neuroblastoma Treatment Production (K MT) Growth Rate (2019-2025)
Figure 65. China Neuroblastoma Treatment Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Neuroblastoma Treatment Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Neuroblastoma Treatment Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Neuroblastoma Treatment Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Neuroblastoma Treatment Market Share Forecast by Type (2025-2032)
Figure 70. Global Neuroblastoma Treatment Sales Forecast by Application (2025-2032)
Figure 71. Global Neuroblastoma Treatment Market Share Forecast by Application (2025-2032)
